Peter Lynch fit · Growth at a reasonable price (GARP)
Is Caris Life Sciences, Inc. Common Stock (CAI) a Peter Lynch Stock?
Some GARP characteristics, but growth or valuation is stretched.
63/100
CSinais mistos
3/6 critérios atendidos
Os critérios de Peter Lynch, aplicados a CAI
PEG ≤ 1.0
chave—
EPS CAGR ≥ 15%
chave26.0%
Revenue CAGR ≥ 10%
93.9%
Net margin > 0
-28.9%
Como CAI pontua em outras estratégias
Dados financeiros ao vivo
Cap. de mercado
$7.05B
P/L (TTM)
-
ROIC (TTM)
-
Margem bruta
61.3%
Perguntas frequentes
What is CAI's Peter Lynch fit score?
CAI scores 63/100 on our Peter Lynch fit engine — grade C. Some GARP characteristics, but growth or valuation is stretched.
Does Peter Lynch actually own CAI?
Our score is computed from financial fundamentals against Peter Lynch's published criteria. We don't claim that Peter Lynch personally owns or recommends CAI.
How often is this score updated?
CAI's Peter Lynch fit score is recomputed daily from the latest TTM financials.
Ferramenta educacional, não é consultoria de investimento. As pontuações são calculadas a partir de dados financeiros públicos contra os critérios publicados de cada estratégia de investimento. Não afirmamos que Peter Lynch possua ou recomende CAI pessoalmente.